Add to favourites

No account yet? Register

For Healthcare Professionals
Slenyto® Therapeutic Bulletin

A succinct summary of the evidence-base for Slenyto® (paediatric prolonged-release melatonin) for the treatment of insomnia in children and adolescents with Autistic Spectrum Disorder and/ or Smith-Magenis Syndrome

To request further information on the Therapeutic Bulletin, please contact us.

PRODUCT: Slenyto®

Related Education and Training items